Clinical Pathway for Alzheimer's Disease in China (CPAD)

CompletedOBSERVATIONAL
Enrollment

1,024

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Mild Cognitive ImpairmentAlzheimer's DiseaseDementia
Trial Locations (28)

Unknown

The First Affiliated Hospital of Anhui Medical University, Hefei

Beijing Anzhen Hospital, Capital Medical University, Beijing

Beijing Shijitan Hospital, Beijing

Chinese PLA General Hospital, Beijing

Peking University First Hospital, Beijing

Peking University People's Hospital, Beijing

Peking University Sixth Hospital, Beijing

Peking University Third Hospital, Beijing

Guangzhou Brain Hospital, Guangzhou

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

The First Hospital of Hebei Medical University, Shijiazhuang

Union Hospital Tongji Mecial College, Huazhong University of Science and Technology, Wuhan

Nanjing Brain Hospital, Nanjing

The Second Affiliated Hospital of Nanchang University, Nanchang

First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an

Shandong Mental Health Center, Jinan

Shandong Provincial Hospital, Jinan

Huadong Hospital Affiliated to Fudan University, Shanghai

Shanghai Changzheng Hospital, Shanghai

Shanghai Mental Health Center, Shanghai

Mental Health Center, West China Hospital, Sichuan University, Chengdu

General Hospital, Tianjin Medical University, Tianjin

Tianjin Huanhu Hospital, Tianjin

The First Teaching Hospital of Xinjiang Medical University, Ürümqi

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou

The First Affiliated Hospital of Zhejiang University, Hangzhou

Ningbo Kangning Hospital, Ningbo

The First Affiliated Hospital, Wenzhou Medical College, Wenzhou

All Listed Sponsors
collaborator

Beijing Novartis Pharma

INDUSTRY

lead

Peking University

OTHER

NCT01779310 - Clinical Pathway for Alzheimer's Disease in China (CPAD) | Biotech Hunter | Biotech Hunter